Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Fission-spectrum neutrons at reduced dose rates enhance neoplastic transformation

Abstract

We have studied the effect of reduced dose rates of radiation on neoplastic transformation using the C3H/1OT1/2 mouse embryo-derived cell line developed by Reznikoff et al.1. In this cell system, transformation can be measured by scoring the foci of piled-up cells that occur after the loss of contact inhibition of growth. We report here that reduction of the dose rates of fission-spectrum neutrons (of mean energy 0.85 MeV) from 38.5 or 10.3 to 0.43 and 0.086 rad min−1 has no effect on cell killing but increases transformation frequency. These data are in contrast to previously published results obtained with 60Co γ rays where reduction of the dose rate resulted in a marked reduction in transformation frequency2,3. Although cancer induction in man involves many factors besides those at the cellular level, the implication from our findings is that the risk of cancer induction due to work-related exposure to neutrons in the nuclear power industry may be greater than previously thought.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Reznikoff, C. A., Brankow, D. W. & Heidelberger, C. Cancer Res. 33, 3231–3238, 3239–3249 (1973).

    CAS  PubMed  Google Scholar 

  2. Han, A., Hill, C. K. & Elkind, M. M. Int. J. Radiat. Biol. 37, 585–589 (1980).

    CAS  Google Scholar 

  3. Han, A., Hill, C. K. & Elkind, M. M. Cancer Res. 40, 3328–3332 (1980).

    CAS  PubMed  Google Scholar 

  4. Han, A. & Elkind, M. M. Radiat. Res. 74, 88–100 (1978).

    Article  ADS  CAS  Google Scholar 

  5. Han, A. & Elkind, M. M. Cancer Res. 39, 123–130 (1979).

    CAS  PubMed  Google Scholar 

  6. Sinclair, W. K. Division of Biological and Medical Research, A. Rep., 29–31 (Argonne National Laboratory, 1970).

  7. Sinclair, W. K. Division of Biological and Medical Research, A. Rep., 152 (Argonne National Laboratory, 1973).

  8. Ngo, F. Q. H., Han, A., Utsumi, H. & Elkind, M. M. Int. J. Radiat. Oncol. Biol. Phys. 3, 187–193 (1977).

    Article  CAS  Google Scholar 

  9. Ngo, F. Q. H., Utsumi, H., Han, A. & Elkind, M. M. Int. J. Radiat. Biol. 36, 521–530 (1979).

    CAS  Google Scholar 

  10. Thomson, J. F., Williamson, F. S., Grahn, D. & Ainsworth, E. J. Radiat. Res. 86(3), 559–572, 572–588 (1981).

    Article  ADS  CAS  Google Scholar 

  11. Vogel, H. H. & Dickson, H. W. Abstr. 29th a. Meet. Radiation Research Society, Minneapolis (1981); Radiat. Res. 87(2), 453 (1981).

    Google Scholar 

  12. Fry, R. J. M. Int. J. Radiat. Oncol. Biol. Phys. 3, 219–226 (1977).

    Article  CAS  Google Scholar 

  13. Ullrich, R. L. & Storer, J. B. Abstr. 29th a. Meet. Radiation Research Society, Minneapolis (1981); Radiat. Res. 87(2), 454 (1981).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hill, C., Buonaguro, F., Myers, C. et al. Fission-spectrum neutrons at reduced dose rates enhance neoplastic transformation. Nature 298, 67–69 (1982). https://doi.org/10.1038/298067a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/298067a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing